APA (7th ed.) Citation

G, R., SJ, P., NI, K., T, P., DM, E., RW, G., . . . RGW, Q. (2026). HSR26-247: Real-World Quality of Life in Patients Treated With Cemiplimab for Advanced Cutaneous Squamous Cell Carcinoma: Results of CemiplimAb Survivorship Epidemiology (CASE) Study. Journal of the National Comprehensive Cancer Network : JNCCN, 24(3.5), . https://doi.org/10.6004/jnccn.2025.7298

Chicago Style (17th ed.) Citation

G, Rabinowits, et al. "HSR26-247: Real-World Quality of Life in Patients Treated With Cemiplimab for Advanced Cutaneous Squamous Cell Carcinoma: Results of CemiplimAb Survivorship Epidemiology (CASE) Study." Journal of the National Comprehensive Cancer Network : JNCCN 24, no. 3.5 (2026). https://doi.org/10.6004/jnccn.2025.7298.

MLA (9th ed.) Citation

G, Rabinowits, et al. "HSR26-247: Real-World Quality of Life in Patients Treated With Cemiplimab for Advanced Cutaneous Squamous Cell Carcinoma: Results of CemiplimAb Survivorship Epidemiology (CASE) Study." Journal of the National Comprehensive Cancer Network : JNCCN, vol. 24, no. 3.5, 2026, https://doi.org/10.6004/jnccn.2025.7298.